1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
StandardAero reported first-quarter 2025 revenue of $1.4 billion, up 16.2% from a year earlier, and net income of $62.9 million, compared with $3.2 million in the prior-year quarter. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, which now includes an estimated $15 million net impact from announced tariffs.
Revenue of $1,435.6 million, up 16.2% from $1,235.7 million; diluted EPS of $0.19 versus $0.01 a year earlier
Net income of $62.9 million, helped by $33.8 million lower interest expense than the prior-year quarter
2025 revenue guidance raised to $5.8 billion to $6.0 billion (from $5.8 billion to $6.0 billion prior range); Adjusted EBITDA guidance raised to $775 million to $795 million from $770 million to $790 million
Arrowhead Pharmaceuticals reported fiscal second-quarter 2025 results for the period ended March 31, 2025, with revenue of $542.7 million versus none a year earlier and net income attributable to the company of $370.4 million, compared with a loss of $125.3 million in the prior-year quarter. The company also said it expects to be funded into 2028 following its Sarepta Therapeutics agreement, and that its CFO, Ken Myszkowski, will retire effective May 13, 2025, succeeded by Daniel Apel.
Net income attributable to Arrowhead was $370.4 million, or $2.75 per diluted share, versus a loss of $1.02 per share a year earlier.
Research and development expenses rose to $133.1 million from $101.1 million.
CFO Ken Myszkowski retires effective May 13, 2025; Daniel Apel succeeds him.
Power Integrations reported first-quarter 2025 net revenue of $105.5 million, up 15% from a year earlier, and GAAP diluted earnings of $0.15 per share, up from $0.07. The board also authorized an additional $50 million for share repurchases, and the company forecast second-quarter revenue of $115 million, plus or minus $5 million, which would be above the first-quarter level.
Q1 2025 net revenues were $105.5 million, up 15% from Q1 2024 and up slightly from Q4 2024.
GAAP diluted EPS was $0.15 versus $0.07 in Q1 2024; non-GAAP diluted EPS was $0.31 versus $0.18.
Q2 2025 revenue is forecast at $115 million, plus or minus $5 million; GAAP gross margin about 55%.
Board authorized an additional $50 million for share repurchases after the company bought back $23.1 million of stock in Q1 and used the remaining $25 million in April.
Essential Utilities reported first-quarter 2025 net income of $283.8 million, or $1.03 per share, up from $265.8 million, or $0.97 per share, a year earlier. Revenue rose 28% to $783.6 million, mainly from regulatory recoveries, higher purchased gas costs and higher regulated natural gas volumes, and the company affirmed its 2025 EPS guidance of $2.07 to $2.11. Shareholders also have a quarterly dividend of $0.3255 per share, payable June 2, 2025 to holders of record on May 13, 2025.
Q1 2025 net income was $283.8 million, or $1.03 per diluted share, versus $265.8 million, or $0.97, in Q1 2024.
Operating revenues were $783.6 million, up 28% from $612.1 million.
2025 diluted EPS guidance of $2.07 to $2.11 was affirmed, and long-term targets were also affirmed.
Quarterly dividend of $0.3255 per share is payable June 2, 2025 to shareholders of record on May 13, 2025.
V2X's board authorized a share repurchase program of up to $100 million of common stock, effective May 12, 2025, with a three-year term ending May 12, 2028. Shareholders also approved an amended 2014 Omnibus Incentive Plan at the May 8, 2025 annual meeting, which adds 900,000 shares for issuance, while the company noted the buyback is not obligated and can be amended, suspended or discontinued at any time.
Board authorized up to $100 million in common stock repurchases on May 7, 2025, effective May 12, 2025
Program runs three years, ending May 12, 2028, and may be used through open market, block trades, privately negotiated deals or Rule 10b5-1 trading plans
Shareholders approved the Amended Omnibus Plan with 23,732,884 votes for and 5,322,908 against, adding 900,000 shares
Filing states the company is not required to repurchase any shares
Macerich reported first-quarter 2025 results on May 12, 2025. The net loss attributable to the company was $50.1 million, or $0.20 per diluted share, compared with $126.7 million, or $0.59 per share, a year earlier, while total revenues rose to $249.2 million from $208.8 million. FFO excluding certain items was $87.4 million, or $0.33 per share, the same per-share figure as a year earlier, but portfolio occupancy fell to 92.6% from 93.4%.
Total revenues were $249.2 million for the quarter, up from $208.8 million in the first quarter of 2024.
Net loss attributable to the company was $50.1 million ($0.20 per diluted share), versus $126.7 million ($0.59 per share) a year earlier.
FFO excluding certain items was $87.4 million ($0.33 per share), compared with $74.6 million ($0.33 per share).
Portfolio occupancy was 92.6% at March 31, 2025, down from 93.4% at March 31, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.